glp-1 drug GLP1 Use For Weight Loss Has Soared Costing Billions Are Pills the Next Big

Compounded tirzepatide is a good and affordable choice for weight loss

Watson, J

However, most of these studies used standard doses approved for diabetes or obesity, and dedicated trials examining low-dose GLP-1 specifically for inflammatory conditions are lacking

Its a small trial with only 1-year follow up and lacking hard endpoints such as hospitalization or cardiovascular deaths, but the results for symptomatic relief and gain in physical activity are certainly very encouraging

DOI: 10.1007/s00394-025-03618-9, Liu, Y., Cotillard, A., Vatier, C., et al

Results vary based on starting weight, diet, exercise, and adherence